Company: PRME
Filing Date: 2025-04-22
Form Type: DEFA14A
Source: 0001628280-25-018706
Chunk: 1

Company: Prime Medicine, Inc.
Filing Date: 2025-04-22
Form: DEFA14A
Chunk 1
---
-1639 (toll-free from the U.S., U.S. territories and Canada) or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.
Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. Voting Items Board Recommends V70764-P28496 THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming 2025 Annual Meeting. Please follow the instructions on the reverse side to vote these important matters. 1. To elect Thomas Cahill, M.D., Ph.D. and Robert Nelsen as Class III Directors. For Nominees: 01) Thomas Cahill, M.D., Ph.D. 02) Robert Nelsen 2. To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. For NOTE: Such other business as may properly come before the meeting or any continuations, adjournments, and postponements thereof.